SCHEMBL15536229

SCHEMBL15536229

CC1(CO)CCC(C(F)(F)F)CC1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.34
SCN9A Q15858 2/20 0.33
ALDH1A1 P00352 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21075289 0.82 ALDH1A1 (0.32) SCN9AALDH1A1TDP1
SCHEMBL17428576 0.82 ALDH1A1 (0.32) SCN9AALDH1A1TDP1
SCHEMBL28233959 0.78 SCN9A (0.33) SCN9AALDH1A1TDP1
SCHEMBL30976057 0.77 EPHX1 (0.37) EPHX1
SCHEMBL17003738 0.77 KDM4E (0.38) EPHX1ALDH1A1TDP1
SCHEMBL17339729 0.75 KDM4E (0.51) EPHX1ALDH1A1TDP1
SCHEMBL19483163 0.75 ESR2 (0.36) ALDH1A1TDP1
SCHEMBL14047871 0.75 ESR2 (0.36) ALDH1A1TDP1
SCHEMBL16449045 0.74 ALDH1A1 (0.36) ALDH1A1TDP1
SCHEMBL26196760 0.74 EPHX1 (0.42) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104718188-B The benzamides of N- substitutions and its purposes in treating pain 基因泰克公司 2018-08-21 CN disclosed
CN-104718188-A N-substituted benzamides and their use in the treatment of pain GENENTECH INC 2015-06-17 CN disclosed
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 EP disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO disclosed